MAOB and substance withdrawal syndrome: However, our current knowledge of rasagiline withdrawal syndrome remains incomplete, and future studies are needed both to systematically identify the presence of withdrawal syndrome and to determine if withdrawal of other MAO-B inhibitors could induce similar symptoms.